Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,932,355
- Total 13F shares
- 3,826,666
- Share change
- +310,793
- Total reported value
- $10,790,008
- Put/Call ratio
- 22%
- Price per share
- $2.82
- Number of holders
- 35
- Value change
- +$478,855
- Number of buys
- 16
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05464T104:
Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
572,701
|
$1,976,000 | — | 30 Sep 2018 | |
| ALETHEA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
547,443
|
$1,889,000 | — | 30 Sep 2018 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.85%
|
416,458
|
$1,437,000 | — | 30 Sep 2018 | |
| FMR LLC |
13F
|
Company |
0.85%
|
416,252
|
$1,436,000 | — | 30 Sep 2018 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.83%
|
404,145
|
$1,394,000 | — | 30 Sep 2018 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.68%
|
332,400
|
$1,147,000 | — | 30 Sep 2018 | |
| Opus Point Partners Management, LLC |
13F
|
Company |
0.25%
|
120,150
|
$415,000 | — | 30 Sep 2018 | |
| Endurant Capital Management LP |
13F
|
Company |
0.19%
|
95,185
|
$328,000 | — | 30 Sep 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
94,205
|
$325,000 | — | 30 Sep 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
88,000
|
$304,000 | — | 30 Sep 2018 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.13%
|
63,365
|
$219,000 | — | 30 Sep 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.11%
|
55,912
|
$193,000 | — | 30 Sep 2018 | |
| Mariner, LLC |
13F
|
Company |
0.08%
|
41,525
|
$143,000 | — | 30 Sep 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
40,698
|
$140,000 | — | 30 Sep 2018 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.08%
|
40,000
|
$138,000 | — | 30 Sep 2018 | |
| BALDWIN WEALTH PARTNERS LLC/MA |
13F
|
Company |
0.06%
|
30,551
|
$105,000 | — | 30 Sep 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
30,453
|
$105,000 | — | 30 Sep 2018 | |
| Walleye Trading LLC |
13F
|
Company |
0.06%
|
28,323
|
$98,000 | — | 30 Sep 2018 | |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd |
13F
|
Company |
0.04%
|
19,958
|
$69,000 | — | 30 Sep 2018 | |
| Walleye Capital LLC |
13F
|
Company |
0.04%
|
17,838
|
$62,000 | — | 30 Sep 2018 | |
| FORBES J M & CO LLP |
13F
|
Company |
0.03%
|
15,066
|
$52,000 | — | 30 Sep 2018 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
13,195
|
$46,000 | — | 30 Sep 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
11,200
|
$39,000 | — | 30 Sep 2018 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.02%
|
10,400
|
$36,000 | — | 30 Sep 2018 | |
| Sandy Spring Bank |
13F
|
Company |
0.02%
|
8,755
|
$30,000 | — | 30 Sep 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
7,010
|
$24,000 | — | 30 Sep 2018 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
4,034
|
$14,000 | — | 30 Sep 2018 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.01%
|
3,236
|
$11,000 | — | 30 Sep 2018 | |
| McAdam, LLC |
13F
|
Company |
0%
|
2,000
|
$7,000 | — | 30 Sep 2018 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0%
|
2,000
|
$7,000 | — | 30 Sep 2018 | |
| Westbourne Investment Advisors, Inc. |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 30 Sep 2018 | |
| Iron Gate Global Advisors LLC |
13F
|
Company |
0%
|
250
|
$1,000 | — | 30 Sep 2018 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3
|
$10 | — | 30 Sep 2018 |
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q4 2018
As of 31 Dec 2018,
Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,826,666 shares.
The largest 10 holders included
Alethea Capital Management, LLC, STIFEL FINANCIAL CORP, Sio Capital Management, LLC, Vanguard Group Inc, ROYCE & ASSOCIATES LP, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., Endurant Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
33
Q4 2018 holders
35
Holder diff
2
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.